Previous 10 | Next 10 |
Gainers: Helios and Matheson Analytics ( OTCPK:HMNY ) +42% . McDermott International (NYSE: MDR ) +31% . Midatech Pharma plc (NASDAQ: MTP ) +30% . Stage Store (NYSE: SSI ) +26% . San Juan Basin Royalty Trust (NYSE: SJT ) +20% . Interlink Electronics ( OTCPK:LINK ) +20% . California ...
Shares of Akorn ( AKRX ) have fallen nearly 40% since I last wrote about the company in May. Although the operations of the business have performed in-line with expectations, uncertainty around Akorn’s capital structure as well as another FDA warning letter have weighed on market se...
Akorn Inc (NASDAQ:AKRX) has received FDA approval for a nasal spray aimed at treating allergies, boosting Akorn stock over 10%. Akorn is a leading specialty generic pharmaceutical company based in Amityville, New York that develops, manufactures, and markets generic and brande...
LAKE FOREST, Ill., Aug. 26, 2019 (GLOBE NEWSWIRE) -- Akorn, Inc. (Nasdaq: AKRX), a leading specialty generic pharmaceutical company, today announced that it received a new Abbreviated New Drug Application (ANDA) approval from the U.S. Food and Drug Administration (FDA) for Azelastine H...
U.S. Senator Bernie Sanders (I-VT) and Representative Elijah Cummings (D-MD - 7th district) have launched an investigation targeting Teva Pharmaceutical Industries ( TEVA -8% ), Mylan N.V. ( MYL -7.8% ) and Heritage Pharmaceuticals for allegedly obstructing a Congressional inquiry into...
Akorn, Inc. (AKRX) Q2 2019 Earnings Conference Call August 01, 2019 9:00 AM ET Company Participants Jennifer Bowles - Senior Vice President of Strategy & Investor Relations Douglas Boothe - President & Chief Executive Officer Duane Portwood - Chief Financial Officer Co...
Akorn ( AKRX ) Q2 results : Revenues: $178.1M (-6.7%). More news on: Akorn, Inc., Healthcare stocks news, Earnings news and commentary, Stocks on the move, Read more ...
Akorn (NASDAQ: AKRX ): Q2 Non-GAAP EPS of -$0.02 beats by $0.05 ; GAAP EPS of -$0.89 misses by $0.59 . More news on: Akorn, Inc., Earnings news and commentary, Healthcare stocks news, Read more ...
LAKE FOREST, Ill., Aug. 01, 2019 (GLOBE NEWSWIRE) -- Akorn, Inc. (Nasdaq: AKRX), a leading specialty generic pharmaceutical company, today announced its preliminary financial results for the second quarter of 2019. Second Quarter 2019 and Recent Business Highlights Net revenue was $...
LAKE FOREST, Ill., July 11, 2019 (GLOBE NEWSWIRE) -- Akorn, Inc. (Nasdaq: AKRX), a leading specialty generic pharmaceutical company, today announced that it plans to issue a press release before market open on Thursday, August 1, 2019 outlining its second quarter 2019 financi...
News, Short Squeeze, Breakout and More Instantly...
Akorn Announces FDA-approved Generic Cetrorelix Acetate for Injection 0.25 mg PR Newswire GURNEE, Ill. , Aug. 16, 2022 /PRNewswire/ -- Akorn Operating Company LLC, a specialty pharmaceutical company, announces that it received FDA approval for a generic v...
LAKE FOREST, Ill. , May 20, 2020 /PRNewswire/ -- Akorn, Inc. (Nasdaq: AKRX), a leading specialty pharmaceutical company ("Akorn" or the "Company"), today announced that the Company and its U.S. subsidiaries filed for voluntary protection under Chapter 11 ("Chapter 11") of the U.S. Bankrup...
Are These On Your List Of Penny Stocks To Watch This Week? It can be tough at times to trade penny stocks . Some days there are only a few names to choose from. But there are other days where there seems to be plenty of penny stocks to buy . In either case, having your plan in place can defi...